Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells
C. A. Tsuchida, N. Brandes, R. Bueno…·J. A. Doudna
This study investigates chromosome loss in CRISPR-Cas9-engineered T cells and shows a modified manufacturing process reduces it while preserving editing efficacy.